280 related articles for article (PubMed ID: 34397947)
1. Association of pre-percutaneous coronary flow grade and clinical outcomes in patients with non-ST-segment elevation myocardial infarction: Data from the Korea Acute Myocardial Infarction Registry.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Medicine (Baltimore); 2021 Aug; 100(32):e26947. PubMed ID: 34397947
[TBL] [Abstract][Full Text] [Related]
2. Twelve-month clinical outcomes of acute non-ST versus ST-segment elevation myocardial infarction patients with reduced preprocedural thrombolysis in myocardial infarction flow undergoing percutaneous coronary intervention.
Baek JY; Kang TS; Rha SW; Choi BG; Park SH; Jeong MH
Coron Artery Dis; 2018 Aug; 29(5):416-422. PubMed ID: 29708887
[TBL] [Abstract][Full Text] [Related]
3. Post-procedural TIMI flow grade 2 is not associated with improved prognosis in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary revascularization (PL-ACS registry).
Karwowski J; Poloński L; Gierlotka M; Gąsior M; Bęćkowski M; Kowalik I; Szwed H
Cardiol J; 2016; 23(4):402-10. PubMed ID: 27296160
[TBL] [Abstract][Full Text] [Related]
4. Impact of renin-angiotensin system inhibitors on long-term clinical outcomes in patients with acute myocardial infarction treated with successful percutaneous coronary intervention with drug-eluting stents: Comparison between STEMI and NSTEMI.
Kim YH; Her AY; Jeong MH; Kim BK; Lee SY; Hong SJ; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Atherosclerosis; 2019 Jan; 280():166-173. PubMed ID: 30529829
[TBL] [Abstract][Full Text] [Related]
5. Prediabetes versus type 2 diabetes mellitus based on pre-percutaneous coronary intervention thrombolysis in myocardial infarction flow grade in patients with ST-segment elevation myocardial infarction after successful newer-generation drug-eluting stent implantation.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Diab Vasc Dis Res; 2021; 18(1):1479164121991505. PubMed ID: 33535819
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of immediate invasive strategy in patients with non-ST-segment elevation myocardial infarction.
Sim DS; Jeong MH; Ahn Y; Kim YJ; Chae SC; Hong TJ; Seong IW; Chae JK; Kim CJ; Cho MC; Rha SW; Bae JH; Seung KB; Park SJ;
Int J Cardiol; 2016 Oct; 221():937-43. PubMed ID: 27441472
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of prepercutaneous coronary intervention TIMI flow in patients with ST-segment and non-ST-segment elevation myocardial infarction: Results from the FAST-MI 2010 registry.
Bailleul C; Aissaoui N; Cayla G; Dillinger JG; Jouve B; Schiele F; Ferrières J; Simon T; Danchin N; Puymirat E;
Arch Cardiovasc Dis; 2018 Feb; 111(2):101-108. PubMed ID: 28939193
[TBL] [Abstract][Full Text] [Related]
8. Impact of Postprocedural TIMI Flow on Long-Term Clinical Outcomes in Patients with Acute Myocardial Infarction.
Kim DW; Her SH; Park MW; Cho JS; Kim TS; Kang H; Sim DS; Hong YJ; Kim JH; Ahn Y; Chang K; Chung WS; Seung KB; Jeong MH; Rho TH
Int Heart J; 2017 Oct; 58(5):674-685. PubMed ID: 28966314
[TBL] [Abstract][Full Text] [Related]
9. ST-segment elevation versus non-ST-segment elevation myocardial infarction in current smokers after newer-generation drug-eluting stent implantation.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Lee SJ; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Medicine (Baltimore); 2021 Dec; 100(49):e28214. PubMed ID: 34889307
[TBL] [Abstract][Full Text] [Related]
10. Predictors and implications of coronary infarct artery patency at initial angiography in patients with acute myocardial infarction (from the CADILLAC and HORIZONS-AMI Trials).
Brener SJ; Mehran R; Brodie BR; Guagliumi G; Witzenbichler B; Cristea E; Xu K; Lansky AJ; Stone GW
Am J Cardiol; 2011 Oct; 108(7):918-23. PubMed ID: 21764028
[TBL] [Abstract][Full Text] [Related]
11. Two-Year Clinical Outcomes According to Pre-PCI TIMI Flow Grade and Reperfusion Timing in Non-STEMI After Newer-Generation Drug-Eluting Stents Implantation.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Angiology; 2022 Feb; 73(2):152-164. PubMed ID: 33960211
[TBL] [Abstract][Full Text] [Related]
12. Comparison of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with diabetes mellitus and non-ST-segment elevation myocardial infarction who underwent successful percutaneous coronary intervention.
Byun JK; Choi BG; Rha SW; Choi SY; Jeong MH;
Atherosclerosis; 2018 Oct; 277():130-135. PubMed ID: 30212681
[TBL] [Abstract][Full Text] [Related]
13. Comparison of First- and Second-Generation Drug-Eluting Stents in Patients with ST-Segment Elevation Myocardial Infarction Based on Pre-Percutaneous Coronary Intervention Thrombolysis in Myocardial Infarction Flow Grade.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
J Clin Med; 2021 Jan; 10(2):. PubMed ID: 33478003
[TBL] [Abstract][Full Text] [Related]
14. ST-elevation versus non-ST-elevation myocardial infarction after combined use of statin with renin-angiotensin system inhibitor: Data from the Korea Acute Myocardial Infarction Registry.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Cardiol J; 2022; 29(4):647-659. PubMed ID: 33634844
[TBL] [Abstract][Full Text] [Related]
15. Culprit-only versus multivessel or complete versus incomplete revascularization in patients with non-ST-segment elevation myocardial infarction and multivessel disease who underwent successful percutaneous coronary intervention using newer-generation drug-eluting stents.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Atherosclerosis; 2020 May; 301():54-64. PubMed ID: 32330691
[TBL] [Abstract][Full Text] [Related]
16. Comparison Between Beta-Blockers with Angiotensin-Converting Enzyme Inhibitors and Beta-Blockers with Angiotensin II Type I Receptor Blockers in ST-Segment Elevation Myocardial Infarction After Successful Percutaneous Coronary Intervention with Drug-Eluting Stents.
Kim YH; Her AY; Jeong MH; Kim BK; Lee SY; Hong SJ; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Cardiovasc Drugs Ther; 2019 Feb; 33(1):55-67. PubMed ID: 30632033
[TBL] [Abstract][Full Text] [Related]
17. Impact of acute infarct-related artery patency before percutaneous coronary intervention on 30-day outcomes in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention in the EUROMAX trial.
Rakowski T; Dudek D; van 't Hof A; Ten Berg J; Soulat L; Zeymer U; Lapostolle F; Anthopoulos P; Bernstein D; Deliargyris EN; Steg PG
Eur Heart J Acute Cardiovasc Care; 2018 Sep; 7(6):514-521. PubMed ID: 28631502
[TBL] [Abstract][Full Text] [Related]
18. Association of potent P2Y12 blockers with ischemic and bleeding outcomes in non-ST-segment elevation myocardial infarction.
Sim DS; Jeong MH; Kim HS; Gwon HC; Seung KB; Rha SW; Chae SC; Kim CJ; Cha KS; Park JS; Yoon JH; Chae JK; Joo SJ; Choi DJ; Hur SH; Seong IW; Cho MC; Kim DI; Oh SK; Ahn TH; Hwang JY;
J Cardiol; 2019 Feb; 73(2):142-150. PubMed ID: 30509351
[TBL] [Abstract][Full Text] [Related]
19. Impact of stent generation on 2-year clinical outcomes in ST-segment elevation myocardial infarction patients with multivessel disease who underwent culprit-only or multivessel percutaneous coronary intervention.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Catheter Cardiovasc Interv; 2020 Feb; 95(2):E40-E55. PubMed ID: 31423723
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions].
Zhang DP; Wang LF; Liu Y; Li KB; Xu L; Li WM; Ni ZH; Xia K; Zhang ZY; Yang XC
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):600-607. PubMed ID: 32842271
[No Abstract] [Full Text] [Related]
[Next] [New Search]
